Clinical Trial Update: Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of preoperative intravesical electromotive mitomycin-C for primary non-muscle invasive bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Superficial Bladder Cancer | Phase 3 | Status: COMPLETED